Semaglutides 1015% average weight reduction is well-documented across multiple large-scale trials and represents an established benchmark for GLP-1-based weight loss therapy
WHY CKD MATTERS FOR THE HEART Reduced eGFR and elevated UACR each independently predict CKD progression, CVD events, HF, and allcause mortality, regardless of age, sex, diabetes, or prior CVD
Keywords: observational studies, real-world evidence, effectiveness, cardiovascular prevention, head-to-head comparisons, innovative Introduction Glucagon-like-peptide-1 receptors agonists (GLP-1RAs) are relatively novel drugs for the treatment of type 2 diabetes (T2D) that stimulate the incretin hormone GLP-1
Our semaglutide to tirzepatide conversion chart and the broader semaglutide vs tirzepatide comparison page cover the evidence-based equivalencies that providers use when transitioning patients between these medications
A review in which progestin-only contraceptives were studied highlighted the importance of the follow-up period, since longer follow-up periods (2-3 years) showed twice the degree of weight gain as compared to shorter studies (1 year) (239)
